Acetate is a short-chain fatty acid (SCFA) with two carbon atoms produced by gut microbiota through fermentation of dietary fiber. It is the most abundant SCFA in the colon, absorbed into the portal circulation and distributed systemically to serve as an energy substrate, histone deacetylase (HDAC) inhibitor, and signaling molecule. Acetate influences metabolism, immune function, and inflammation through multiple receptor-mediated and epigenetic mechanisms.
Gut bacteria (particularly Bacteroidetes and Firmicutes) ferment resistant starch and dietary fiber into acetate through anaerobic glycolysis. Acetate is absorbed by colonocytes via MCT1 transporters and enters the portal vein, reaching the liver where it can be converted to acetyl-CoA for energy production or lipogenesis. Acetate activates GPR43 (FFAR2) and GPR41 (FFAR3) receptors on immune cells, adipocytes, and enteroendocrine cells, modulating inflammatory responses and metabolic signaling. As an HDAC inhibitor, acetate promotes histone acetylation, opening chromatin structure and influencing gene expression toward anti-inflammatory profiles. Acetate also serves as a substrate for acetyl-CoA production in peripheral tissues, influencing fatty acid synthesis and energy metabolism.
Acetate levels reflect fiber intake and microbiome fermentation capacity. Low acetate production indicates gut dysbiosis and insufficient fiber intake, contributing to low-grade inflammation and metabolic dysfunction. Increasing dietary fiber to promote acetate production is a foundational cPNI intervention for reducing inflammation, supporting gut barrier integrity, and improving metabolic health.
- Most abundant SCFA, accounting for ~60% of total colonic SCFAs
- Produced primarily by Bacteroidetes and Firmicutes through fiber fermentation
- Activates GPR43/FFAR2 on immune cells to reduce inflammatory cytokine production
- Functions as HDAC inhibitor promoting anti-inflammatory gene expression patterns
- Crosses blood-brain barrier and may influence CNS function
- Supports gut barrier integrity through colonocyte metabolism
- Converted to acetyl-CoA for fatty acid synthesis in liver and adipose tissue
- short-chain fatty acids — acetate is one of three primary SCFAs (with butyrate and propionate)
- butyrate — acetate and butyrate are both SCFAs but butyrate has stronger HDAC inhibition and colonocyte effects
- propionate — acetate and propionate are co-produced during fiber fermentation with different metabolic fates
- dietary fiber — fiber is the substrate for bacterial fermentation producing acetate
- gut microbiota — microbiota ferment fiber to produce acetate
- Bacteroidetes — this phylum is a major acetate producer
- Firmicutes — Firmicutes species contribute to acetate production
- resistant starch — resistant starch is preferentially fermented to acetate
- portal vein — acetate is absorbed from colon and enters portal circulation
- colonocytes — acetate provides energy to colonocytes supporting barrier function
- HDAC inhibitor — acetate inhibits histone deacetylases promoting anti-inflammatory gene expression
- histone modification — acetate increases histone acetylation opening chromatin
- gut barrier — acetate supports tight junction integrity and barrier function
- low-grade inflammation — acetate reduces systemic inflammation through GPR43 activation on immune cells
- gut dysbiosis — dysbiosis reduces acetate production contributing to inflammation
- GPR41 — acetate activates this receptor on enteroendocrine and adipocytes
- GPR43 — acetate activates GPR43/FFAR2 on immune cells reducing inflammatory cytokine production
- acetyl-CoA — acetate is converted to acetyl-CoA for energy and biosynthesis
- lipogenesis — hepatic acetate can be converted to acetyl-CoA for fatty acid synthesis
- metabolic flexibility — acetate availability as alternative fuel source supports metabolic flexibility